• 5967 Citations
  • 40 h-Index
1982 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alberto Garaventa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Neuroblastoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

  • 5967 Citations
  • 40 h-Index
  • 293 Article
  • 4 Review article
  • 1 Chapter
  • 1 Editorial

Conservative management of chylous ascites after oncological surgery for peripheral neuroblastic tumors in pediatric patients

Pio, L., Boccardo, F., Avanzini, S., Paraboschi, I., Granata, C., Garaventa, A., Dessalvi, S., Martucciello, G. & Mattioli, G., Jan 1 2019, In : Lymphology. 52, 1, p. 25-34 10 p.

Research output: Contribution to journalArticle

Chylous Ascites
Pediatrics
Neoplasms
Total Parenteral Nutrition
Incidence

Exosomal microRNAs from longitudinal liquid biopsies for the prediction of response to induction chemotherapy in high-risk neuroblastoma patients: A proof of concept SIOPEN study

Morini, M., Cangelosi, D., Segalerba, D., Marimpietri, D., Raggi, F., Castellano, A., Fruci, D., De Mora, J. F., Cañete, A., Yáñez, Y., Viprey, V., Corrias, M. V., Carlini, B., Pezzolo, A., Schleiermacher, G., Mazzocco, K., Ladenstein, R., Sementa, A. R., Conte, M., Garaventa, A. & 5 others, Burchill, S., Luksch, R., Bosco, M. C., Eva, A. & Varesio, L., Oct 2019, In : Cancers. 11, 10, 1476.

Research output: Contribution to journalArticle

Open Access
Induction Chemotherapy
MicroRNAs
Neuroblastoma
Biopsy
Exosomes

FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial

AIEOP Hodgkin Lymphoma Study Group, I., Lopci, E., Mascarin, M., Piccardo, A., Castello, A., Elia, C., Guerra, L., Borsatti, E., Sala, A., Todesco, A., Zucchetta, P., Farruggia, P., Cistaro, A., Buffardi, S., Bertolini, P., Bianchi, M., Moleti, M. L., Bunkheila, F., Indolfi, P., Fagioli, F. & 2 others, Garaventa, A. & Burnelli, R., Jan 1 2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, 1, p. 97-106 10 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Pediatrics
Multivariate Analysis
Recurrence
Drug Therapy
1 Citation (Scopus)

FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial

AIEOP Hodgkin Lymphoma Study Group, Italy, Jan 1 2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, 1, p. 97-106 10 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Pediatrics
Multivariate Analysis
Recurrence
Drug Therapy
Survivors
Registries
Cause of Death
Mortality
Neoplasms